When in a drug epidemic should the policy objective switch from use reduction to harm reduction?

European Journal of Operational Research

Volumn 201, Issue 1, 2010, Pages 308-318

  Caulkins, Jonathan P ^a,b   Feichtinger, Gustav ^c   Tragler, Gernot ^c   Wallner, Dagmar ^c  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b CARNEGIE MELLON UNIVERSITY   (Qatar)

^c VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Control; Drug policy; Epidemics; Health; OR in societal problem analysis

Indexed keywords

AUSTRALIA; DRUG POLICY; EPIDEMICS; HARM REDUCTION; HIV/AIDS; OR IN SOCIETAL PROBLEM ANALYSIS; PAPER MODELS; PARAMETER CHANGES; PARAMETERIZED; POLICY OBJECTIVES; SOCIAL COST; STATE SPACE;

EPIDEMIOLOGY;

EID: 70249099207     PISSN: 03772217     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejor.2009.03.015     Document Type: Article

References (42)

1. Bass F.M. A new product growth model for consumer durables. Management Science 15 (1969) 215-227
2. Baveja A., Batta R., Caulkins J.P., and Karwan M.H. Modeling the response of illicit drug markets to local enforcement. Socio-Economic Planning Sciences 27 (1993) 73-89
3. Behrens D.A., Caulkins J.P., Tragler G., Haunschmied J.L., and Feichtinger G. A dynamical model of drug initiation: Implications for treatment and drug control. Mathematical Biosciences 159 (1999) 1-20
4. Behrens D.A., Caulkins J.P., Tragler G., and Feichtinger G. Optimal control of drug epidemics: Prevent and treat - but not at the same time. Management Science 46 (2000) 333-347
5. Blower S.M., Koelle K., and Mills J. Health policy modeling: epidemic control, HIV vaccines and risky behavior. In: Kaplan, and Brookmeyer (Eds). Quantitative Evaluation of HIV Prevention Programs (2002), Yale University Press 260-289
6. Bundgaard-Neilsen M. The international diffusion of new technology. Technological Forecasting and Social Change 8 4 (1976) 365-370
7. Caulkins J.P. Local drug markets' Response to focused police enforcement. Operations Research 41 (1993) 848-863
8. Caulkins J.P. Models pertaining to how drug policy should vary over the course of an epidemic cycle. In: Lindgren B., and Grossman M. (Eds). Substance Use: Individual Behavior, Social Interactions, Markets, and Politics, Advances in Health Economics and Health Services Research vol. 16 (2005), Elsevier 407-439
9. Caulkins J.P., and Reuter P. Setting goals for drug policy: Harm reduction or use reduction. Addiction 92 (1997) 1143-1150
10. Caulkins, J.P., Pacula, R., Paddock, S., Chiesa, J., 2002. School-based drug prevention: What kind of drug use does it prevent? MR-1459-RWJ. RAND, Santa Monica, CA.
11. Caulkins J.P., Behrens D.A., Knoll C., Tragler G., and Zuba D. Markov chain modeling of initiation and demand: The case of the US cocaine epidemic. Health Care Management Science 7 4 (2004) 319-329 10.1007/s10729-004-7540-4
12. Caulkins J.P., Dietze P., and Ritter A. Dynamic compartmental model of trends in Australian drug use. Healthcare Management Science 10 2 (2007) 151-162 10.1007/s10729-007-9012-0
13. Collins, D.J., Lapsley, H.M., 2002. Counting the cost: Estimates of the social costs of drug abuse in 1998-99. Commonwealth of Australia, Canberra.
14. Coomber R. Pusher Myths: Re-Situating the Drug Dealer (2006), Free Association Books, London
15. Dave, D., 2004. Illicit Drug Use Among Arrestees and Drug Prices. NBER Working Paper #10648. Cambridge, MA. (http://ideas.repec.org/p/nbr/nberwo/10648.html).
16. Drummond, M., 2004. Return on Investment in Needle and Syringe Exchange Programs in Australia. Commonwealth Department of Health and Ageing, Commonwealth of Australia, Canberra.
17. Easingwood C.J., Mahajan J., and Muller E. A nonuniform influence innovation diffusion model of new product acceptance. Marketing Science 2 3 (1983) 273-295
18. Ferrence R. Diffusion theory and drug use. Addiction 96 (2001) 165-173
19. Gable R.S. Comparison of acute lethal toxicity of commonly abuse psychoactive substances. Addiction 99 (2004) 686-696
20. Grossman, M., 2004. Individual Behaviors and Substance Abuse: The Role of Price. NBER Working Paper No. 10948. Cambridge, MA.
21. Harwood H., Fountain D., and Livermore G. The Economic Costs of Alcohol and Drug Abuse in the United States, 1992 (1998), National Institutes on Drug Abuse, Rockville, MD
22. Kirby K.N., and Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 99 (2004) 461-471
23. Kleiman M.A.R. Crackdowns: The effects of intensive enforcement on retail heroin dealing. In: Chaiken M.R. (Ed). Street-Level Drug Enforcement: Examining the Issues (1988), National Institute of Justice, Washington, DC
24. Kleiman M.A.R. Enforcement swamping: A positive-feedback mechanism in rates of illicit activity. Mathematical and Computer Modeling 17 (1993) 65-75
25. Kleiman M.A.R. "Economic cost" measurements, damage minimization and drug abuse control policy. Addiction 94 (1999) 634-638
26. Law M.G., Dore G.J., Bath N., Thompson S., Crofts N., Dolan K., Giles W., Gow P., Kaldor J., Loveday S., Powell E., Spencer J., and Wodak A. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology 32 (2003) 717-724
27. MacCoun R.J. Toward a psychology of harm reduction. American Psychologist 53 (1998) 1199-1208
28. McCaffrey, B.R., 1998. Legalization would be the Wrong Direction. Los Angeles Times, July 27.
29. McKetin, R., McLaren, J., Kelly, E., Hall, W., Hickman, M., 2005. Estimating the Number of Regular and Dependent Methamphetamine Users In Australia. Technical Report 230. NDARC, Sydney.
30. Moore, T.J., 2005. Monograph No 01: What is Australia's "Drug Budget"? The policy mix of illicit drug-related government spending in Australia. DPMP Monograph Series. Fitzroy: Turning Point Alcohol and Drug Centre.
31. Moore T.J., and Caulkins J.P. How cost-of-illness studies can be made more useful for illicit drug policy analysis. Applied Health Economics and Health Policy 5 (2006) 75-85
32. Musto D. The American Disease. second ed. (1987), Yale University Press, New Haven: CT
33. Nordt C., and Stohler R. Incidence of heroin use in Zurich, Switzerland: A treatment case register analysis. The Lancet 367 (2006) 1830-1834
34. Noymer A. The transmission and persistence of 'Urban Legends': Sociological application of age-structured epidemic models. Journal of Mathematical Sociology 25 (2001) 299-323
35. Reuter P. Are calculations of the economic costs of drug abuse either possible or useful?. Addiction 94 (1999) 635-637
36. Reuter P., and Caulkins J.P. Redefining the goals of drug policy: Report of a working group. American Journal of Public Health 85 8 (1995) 1059-1063
37. Rigter H. What drug policies cost: Drug policy spending in the Netherlands in 2003. Addiction 101 (2006) 323-329
38. Riley K.J. Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six U.S. cities (1997), National Institute of Justice, Washington, DC
39. Tragler G., Caulkins J.P., and Feichtinger G. Optimal dynamic allocation of treatment and enforcement in illicit drug control. Operations Research 49 (2001) 352-362
40. United Nations Office on Drugs and Crime, 2005. World Drug Report. Oxford University Press.
41. Weatherburn D., Jones C., Freeman K., and Makkai T. Supply control and harm reduction: Lessons from the Australian Heroin 'Drought'. Addiction 98 (2003) 83-91
42. Winkler D., Caulkins J.P., Behrens D., and Tragler G. Estimating the relative efficiency of various forms of prevention at different stages of a drug epidemic. Socio-Economic Planning Sciences 38 (2004) 43-56